- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07268716
Essai clinique randomisé et contrôlé visant à évaluer l'efficacité d'informations personnalisées pour les patients et d'un suivi numérique ambulatoire volontaire géré par les patients (I-POD) en complément du traitement standard conformément aux directives nationales dans le NTP chez les patients adultes traumatisés en Norvège. (POSTRAUMA)
Étude clinique randomisée contrôlée visant à évaluer l'efficacité d'informations personnalisées aux patients et d'un suivi numérique ambulatoire volontaire géré par les patients en complément du traitement standard conformément aux directives nationales chez les patients adultes traumatisés en Norvège (l'essai POSTRAUMA).
The POSTRAUMA trial is a clinical trial at The Regional trauma centre of Western Norway, Haukeland University Hospital.
Trauma is the leading cause of death worldwide in patients aged 1-45 years. In Norway, approximately 10,000 patients are admitted to hospital annually due to trauma, with 66% being male. The mean age is 43 years for male and 48 years for female, indicating a relatively young patient population.
While mortality rates are decreasing, a significant proportion of trauma survivors experience long-term disabilities, reduced quality of life, and difficulties in returning to work. These consequences impose substantial burdens on individuals, families, and society. Considering these issues, a shift in focus is needed-from survival alone to long-term functional recovery and quality of life after trauma.
Severe trauma often requires long-term follow-up, both physically and psychosocially. Traditional follow-up can be fragmented and not tailored to individual needs. Digital patient monitoring and tailored information have the potential to improve patient pathways, but knowledge about how these are experienced by patients is limited.
The goal is to find out if Norwegian trauma patients who receive tailored patient information and patient-managed outpatient digital follow-up, in addition to standard treatment have:
- Less disability
- Return more often to work
- Improved quality of life
The study population are Norwegian trauma patients, 16 years or older at date of inclusion, who are admitted to Haukeland University hospital (HUS) following trauma with trauma team activation. 256 patients will be included in this trial.
Participants will:
- Answer a questionnaire at inclusion, one month, 6 months and 12 months.
- Participants in the intervention group will be invited to digital outpatient follow up one month after the accident.
- Some participants will be interviewed about how they experienced their trauma follow up.
Aperçu de l'étude
Statut
Les conditions
Description détaillée
Trauma is the leading cause of death worldwide in patients aged 1-45 years. Injuries and violence contribute to approximately 10% of all disability-adjusted life years globally. In Norway, approximately 10,000 patients are admitted to hospital annually due to trauma, with 66% being male. The mean age is 43 years for male and 48 years for female, indicating a relatively young patient population compared to other medical cohorts. The socioeconomic and functional implications of trauma are significant. With the expected demographic shift toward an aging population in Norway, the incidence of trauma among older adults is also expected to increase, placing greater demands on in-hospital trauma and rehabilitation services. Socioeconomic status, gender and age have been identified as key predictors of long-term outcomes following trauma, with female and individuals with lower education levels or ongoing compensation claims often reporting poorer outcomes.
While mortality rates are decreasing due to advancements in trauma systems, prevention strategies and medical care, a significant proportion of trauma survivors experience longterm disabilities, reduced quality of life, and difficulties in returning to work. These consequences impose substantial burdens on individuals, families, and society. Considering these issues, a shift in focus is needed-from survival alone to long-term functional recovery and quality of life after trauma.
Severe trauma often requires long-term follow-up, both physically and psychosocially. Traditional follow-up is often fragmented and not tailored to individual needs. Digital patient monitoring and tailored information have the potential to improve patient pathways, but knowledge about how these are experienced by patients, relatives, and healthcare professionals is limited.
This study aims to investigate how early rehabilitation and patient-centred care pathways can improve short and long-term outcomes for trauma patients. The objectives of the POSTRAUMA-trial is to assess the efficacy of a tailored patient information and patient managed outpatient digital follow-up (I-POD), as an adjunct to standard treatment according to the national guidelines in the National Trauma Plan (NTP) among adult trauma patients in Norway. The main research question is whether participants in the intervention group have less disability and improved health-related quality of life 6 months after the accident compared to the control group which receives standard treatment alone?
The latter part of the trial is a qualitative study which will follow the consolidated criteria for reporting qualitative studies (COREQ). SI will through in-dept and semi-structured interviews explore the participants experiences following trauma in general, and more specific to evaluate how the written patient information and digital follow-up was perceived. The SI will encourage the participants to talk about issues regarding this by asking open-ended questions in one-to-one interviews. The illness trajectory framework will be used as a theoretical framework, along with the WHOs International Classification of Functioning, Disability and Health (ICF) to ensure that preinjury, physical and biopsychosocial factors are evaluated.
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Marianne Wesnes, Cand. med.
- Numéro de téléphone: +47 996 20 649
- E-mail: marianne.wesnes@helse-bergen.no
Sauvegarde des contacts de l'étude
- Nom: Geir Arne Sunde, Ph.d.
- Numéro de téléphone: +47 992 04 008
- E-mail: geir.arne.sunde@helse-bergen.no
Lieux d'étude
-
-
-
Bergen, Norvège, 5021
- Surgical Department, Haukeland University hospital
-
Contact:
- Marianne Wesnes, Cand.med
- Numéro de téléphone: +47 996 20 649
- E-mail: marianne.wesnes@helse-bergen.no
-
Contact:
- Geir Arne Sunde, Ph.d
- Numéro de téléphone: +47 992 04 008
- E-mail: geir.arne.sunde@helse-bergen.no
-
Sous-enquêteur:
- Marianne Wesnes, Cand.med
-
Chercheur principal:
- Geir Arne Sunde, Ph.d
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- 16 years or older
- Fulfils the national criteria for TTA and admitted to HUS following trauma
- Included in NTR database
- Able to give informed consent
Exclusion Criteria:
- 15 years or younger
- Not included in NTR database
- Deceased before discharge from the hospital.
- Not able to give informed consent
- Insufficient command of the Norwegian language
- Foreign tourists or nationals
- Suicide attempt or serious self-inflicted trauma
- Serious psychiatric disorders or serious ongoing substance abuse
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Aucune intervention: Control group
Standard treatment and follow up after trauma according to national guidelines in the National trauma plan. |
|
|
Comparateur actif: Intervention group
Tailored patient information and patient-managed outpatient follow up as an adjunct to standard treatment according to national guidelines in the National trauma plan |
The objective of the POSTRAUMA-trial is to assess if the I-POD intervention combined with standard treatment according to national guidelines, lead to less disability measured by EQ5D-index, better health-related quality of life measured by EQ-VAS and increased return to studies and work compared to standard treatment after trauma.
Autres noms:
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
EuroQol five-dimension utility score (EQ5D-index) from baseline to 6 months after the trauma in both groups.
Délai: From baseline to 6 months after the trauma
|
The primary objective is to assess the efficacy of the I-POD-intervention as an adjunct to standard treatment after trauma according to national guidelines in adult patients in Norway. The efficacy is measured as the primary endpoint: EuroQol five-dimension utility score (EQ5D-index) from baseline to 6 months after the trauma in both groups. EQ5D-index ranges from - 0,59 (worst score) to 1 (perfect health, best score). 0 equals death. Baseline is defined as the time of inclusion. The I-POD intervention is a tailored patient Information and Patient-managed Outpatient Digital follow-up treatment. |
From baseline to 6 months after the trauma
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Différences dans le retour au travail (RTW) entre le groupe témoin et le groupe d'intervention à 1 mois, 6 mois et 12 mois après le traumatisme, selon les données déclarées par les patients à 1 mois, et à 6 mois et 12 mois selon les données NTR mesurées de manière dichotomique (oui/non)
Délai: De la valeur initiale à 1 mois, 6 mois et 12 mois
|
De la valeur initiale à 1 mois, 6 mois et 12 mois
|
|
|
Differences in EuroQol five-dimension utility score (EQ5D-index) between the control group and the intervention group from baseline to 1 month and 12 months after the trauma.
Délai: Baseline to 1 month and 12 months after the trauma
|
EQ5D-index ranges from - 0,59 (worst score) to 1 (perfect health, best score). 0 equals death. |
Baseline to 1 month and 12 months after the trauma
|
|
Differences in HRQoL between the control group and the intervention group from baseline to 1 month, 6 months and 12 months after the trauma, measured by EuroQol visual analogue scale (EQ-VAS).
Délai: Baseline to 1 month, 6 months and 12 months after the trauma
|
The EQ-VAS (EuroQol Visual Analogue Scale) is a standard tool used with the EQ-5D health questionnaire to measure a person's self-rated overall health on a vertical scale from 0 (worst imaginable health) to 100 (best imaginable health). |
Baseline to 1 month, 6 months and 12 months after the trauma
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Geir Arne Sunde, Ph.d, Haukeland University hospital, Surgical Department
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 909877
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Sharing of privacy data is not within the scope of the ethical approval granted by REK West.
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .